WAC pricing and generic prescription drug disclosure as required by Colorado Revised Statutes 12-280-308
Wholesale Acquisition Cost (WAC), also known as list price, is established by Intra-Cellular Therapies, Inc. WAC may not reflect the price paid by patients or insurers. Patients with insurance may pay less than the WAC price.
CAPLYTA® (lumateperone) capsules
The WAC price is $52.31 per CAPLYTA capsule and $1,569.17 per bottle.*
However, eligible commercially insured patients may pay as little as $0 for the first two fills up to a 30-day supply, and $15 for subsequent fills up to a 90-day supply of CAPLYTA.†
†This offer is valid for eligible new or existing patients who are filling a prescription for CAPLYTA. Eligible patients must be 18 years of age or older, residents of the U.S., excluding Puerto Rico and have a valid prescription for CAPLYTA for a Food & Drug Administration approved indication. This Savings program is valid ONLY for patients with private commercial insurance and NOT valid for prescriptions reimbursed under Medicaid, a Medicare drug benefit plan, TRICARE, or other federal or state health programs. Offer is only good at participating retail pharmacies. Offer is not transferable, is not insurance, has no cash value, and may not be used in combination with other offers. Void if prohibited by law, taxed, or restricted.
All participants are responsible for reporting the receipt of all Program benefits as required by their insurance provider. No party may seek reimbursement for all or any of the benefit received through this Program. Intra-Cellular Therapies, Inc. reserves the right to rescind, revoke or amend the Program without notice at any time. Additional eligibility criteria apply. Click here for full Eligibility Criteria and Terms and Conditions.
The products listed below are generic prescription drugs for CAPLYTA:
- There are no generic prescription drugs available for CAPLYTA
- Examples of generic prescription drugs within the atypical antipsychotic class include risperidone,
olanzapine, and clozapine
Source: AnalySource® 01/01/2023 as reprinted with permission by First Databank, Inc. All rights reserved. ©2023
This information is current as of January 2023.